Base
N3051952019-08-01New YorkClassification

The tariff classification of Medroxyprogesterone Injection in dosage form, from Italy

U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced

Cross-Source Intelligence

Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-29 · Updates monthly

Summary

The tariff classification of Medroxyprogesterone Injection in dosage form, from Italy

Ruling Text

N305195 August 1, 2019 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3006.60.0000 Ms. Rhona M. Keeler NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road, Cork T12 XN72 Ireland RE: The tariff classification of Medroxyprogesterone Injection in dosage form, from Italy Dear Ms. Keeler: In your letter dated July 9, 2019, you requested a tariff classification ruling. Medroxyprogesterone Injection is a medicinal preparation containing Medroxyprogesterone Acetate, a derivative of progesterone, as the active ingredient. It is indicated for use, among other things, as a contraceptive and to control uterine bleeding. Medroxyprogesterone Injection will be imported in 150 mg/ml pre-filled syringes and 150 mg/ml vials for injection. The applicable subheading for the Medroxyprogesterone Injection in dosage form will be 3006.60.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Pharmaceutical goods specified in note 4 to this chapter: Chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at judy.h.lee@cbp.dhs.gov. Sincerely, Steven A. Mack Director National Commodity Specialist Division